Direkt zum Inhalt
Merck
  • Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.

Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2014-05-13)
F J Reen, D F Woods, M J Mooij, M N Chróinín, D Mullane, L Zhou, J Quille, D Fitzpatrick, J D Glennon, G P McGlacken, C Adams, F O'Gara
ZUSAMMENFASSUNG

Chronic respiratory infections are a leading global cause of morbidity and mortality. However, the molecular triggers that cause respiratory pathogens to adopt persistent and often untreatable lifestyles during infection remain largely uncharacterised. Recently, bile aspiration caused by gastro-oesophageal reflux (GOR) has emerged as a significant complication associated with respiratory disease, and cystic fibrosis (CF) in particular. Based on our previous finding that the physiological concentrations of bile influence respiratory pathogens towards a chronic lifestyle in vitro, we investigated the impact of bile aspiration on the lung microbiome of respiratory patients. Sputum samples (n = 25) obtained from a cohort of paediatric CF patients were profiled for the presence of bile acids using high-resolution liquid chromatography-mass spectrometry (LC-MS). Pyrosequencing was performed on a set of ten DNA samples that were isolated from bile aspirating (n = 5) and non-bile aspirating (n = 5) patients. Both denaturing gradient gel electrophoresis (DGGE) and pyrosequencing revealed significantly reduced biodiversity and richness in the sputum samples from bile aspirating patients when compared with non-aspirating patients. Families and genera associated with the pervasive CF microbiome dominated aspirating patients, while bacteria associated with the healthy lung were most abundant in non-aspirating patients. Bile aspiration linked to GOR is emerging as a major host trigger of chronic bacterial infections. The markedly reduced biodiversity and increased colonisation by dominant proteobacterial CF-associated pathogens observed in the sputum of bile aspirating patients suggest that bile may play a major role in disease progression in CF and other respiratory diseases.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Methanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Acetonitril, HPLC Plus, ≥99.9%
Sigma-Aldrich
Methanol, HPLC Plus, ≥99.9%
Sigma-Aldrich
Acetonitril, ACS reagent, ≥99.5%
Sigma-Aldrich
Acetonitril, anhydrous, 99.8%
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Methanol, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Methanol, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Methanol, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Methanol, Absolute - Acetone free
USP
Methylalkohol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Methanol, BioReagent, ≥99.93%
Supelco
Methanol, analytical standard
Supelco
Methanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Lithocholsäure, ≥95%
Sigma-Aldrich
Deoxycholsäure, ≥98% (HPLC)
Sigma-Aldrich
Chenodesoxycholsäure
Sigma-Aldrich
Cholinsäure, from bovine and/or ovine, ≥98%
Sigma-Aldrich
Acetonitril, biotech. grade, ≥99.93%
Sigma-Aldrich
Acetonitril, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ursodesoxycholsäure, ≥99%
Sigma-Aldrich
Acetonitril, suitable for DNA synthesis, ≥99.9% (GC)
Supelco
Acetonitril (unverdünnt), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Deoxycholsäure, ≥99.0% (T)
Supelco
Acetonitril, analytical standard